DL-tert-Leucine is a non-proteinogenic amino acid derivative classified as a tert-leucine stereochemical mixture, featuring an amino acid backbone with a carboxylic acid and an amino group attached to a branched side chain bearing a tert-butyl-like substitution pattern. The molecule contains a primary amine and a free carboxyl group, and the "DL" designation indicates the presence of both stereoisomeric forms at the chiral center when applicable. DL-tert-Leucine is used in peptide and amino acid chemistry workflows to introduce a sterically bulky, hydrophobic side chain motif for structure-activity studies, conformational investigations, and the synthesis of modified peptides or amino acid building blocks.
DL-tert-Leucine is a racemic tert-leucine amino acid derivative featuring a branched aliphatic side chain that increases steric bulk while retaining the amino acid backbone with a stereogenic center at the α-carbon. The compound bears an amino functionality and a carboxylic acid (or carboxyl-derived reactivity depending on its salt/derivatized form), enabling standard amino acid coupling chemistries after appropriate activation. The tert-leucine side chain is resistant to many mild transformations yet can be leveraged for conformational effects in peptide and peptidomimetic scaffolds, where steric constraints influence local structure. As a DL (D/L) mixture, it functions as a chiral synthesis feedstock for producing enantiopure analogs or as a controlled-configuration component when racemic incorporation is acceptable for screening and materials research.
1. Peptide Synthesis
DL-tert-Leucine is applied in peptide building and peptide coupling development where amino acid side-chain sterics can modulate backbone conformations and protease recognition. The α-amino and carboxyl groups support conversion into protected amino acid forms and subsequent amide bond formation using common peptide coupling activation strategies. Racemic stereochemistry allows preparation of mixed stereochemical peptide libraries for structure-activity relationship studies, while enantiopure separation or downstream resolution can be used when stereochemical specificity is required. Incorporation into short peptides and peptidomimetic sequences enables generation of analogs that probe how bulky hydrophobic residues affect folding propensity and binding-site fit.
2. Chiral Resolution Feedstock
DL-tert-Leucine serves as a chiral amino acid intermediate for manufacturing and research routes that require access to enantiopure tert-leucine derivatives. The presence of a single stereocenter at the α-carbon makes the material suitable for resolution strategies that produce D- and L-tert-leucine building blocks for stereochemically defined peptide synthesis. The amino acid functionality supports conversion to protected derivatives, allowing selective crystallization, salt formation, or derivative-based separation approaches prior to coupling chemistry. Downstream use includes preparing enantiopure amino acid esters, N-protected amino acids, and side-chain-compatible intermediates used in fine chemical synthesis and stereocontrolled scaffold construction.
3. Peptidomimetics And SAR
DL-tert-Leucine is used in peptidomimetic construction and SAR-focused molecular design where bulky, branched hydrophobic substitution can tune conformational ensembles and intermolecular contacts. The amino acid backbone enables systematic derivatization into amide-linked analogs, while the tert-leucine side chain can be retained to maintain steric and hydrophobic character across series. Racemic incorporation supports early-stage screening of stereochemical effects, and subsequent enantiopure refinement can be performed when assay data indicate stereospecific binding or stability trends. The resulting analogs can function as biochemical research reagents and as scaffold components for mapping residue-level contributions to molecular recognition.
4. Protected Amino Acid Chemistry
DL-tert-Leucine is suitable for protected amino acid synthesis routes that prepare N-protected and/or carboxyl-activated derivatives for controlled peptide coupling. The amino group can be protected to suppress side reactions during activation and coupling, while carboxyl functionality can be transformed into ester or activated acid equivalents depending on the selected synthetic sequence. The branched side chain tolerates many standard protection and deprotection conditions, supporting its use as a stable chiral building block precursor in peptide manufacturing workflows. Protected derivatives derived from DL-tert-Leucine can be employed to assemble C-terminal or internal residues in peptide fragments and to generate intermediates for subsequent functional group transformations.
5. Process Chemistry Intermediate
DL-tert-Leucine is employed as an industrial amino acid intermediate in process chemistry where racemic feedstocks simplify supply and enable scalable conversion into downstream protected building blocks. The molecule's amino acid reactivity allows integration into manufacturing streams that produce activated amino acid derivatives for peptide and specialty chemical production. Steric properties of the tert-leucine side chain can influence crystallization behavior and solid-state handling of intermediates, which may be relevant when designing robust manufacturing routes for protected amino acid forms. Downstream products include peptide synthesis reagents, peptidomimetic precursors, and chiral-precursor derivatives that support industrial fine chemical synthesis and applied biochemical research manufacturing.
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More